Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2017 second-quarter earnings
J&J Building Flag Summer

What you need to know about Johnson & Johnson’s 2017 second-quarter earnings

Check out this infographic breakdown of the company’s second-quarter 2017 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Johnson & Johnson shared financial information this morning about its second-quarter performance in 2017.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

For more details about the company’s second-quarter 2017 results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.

2017 Second Quarter Earnings

Johnson & Johnson’s 2017 2nd-Quarter Earnings

Read the earnings press release, which includes full financial data for the second quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson quarterly and full-year results here.

More from Johnson & Johnson

“The surgical devices I design for Johnson & Johnson can help speed healing and save lives”

Candice Otrembiak’s work combines her love of science with her natural problem-solving skills. The result: high-tech devices that help make medical procedures more efficient for surgeons and safer for patients.

Johnson & Johnson named a 2025 Fortune World’s Most Admired Company

A dedication to innovation and social responsibility are just two of the qualities that helped the company garner a coveted spot on the list for the 23rd year in a row.

What you need to know about Johnson & Johnson’s 2024 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and full-year performance, with highlights from its Innovative Medicine and MedTech businesses.